Literature DB >> 21642358

Common genetic variants related to genomic integrity and risk of papillary thyroid cancer.

Gila Neta1, Alina V Brenner, Erich M Sturgis, Ruth M Pfeiffer, Amy A Hutchinson, Briseis Aschebrook-Kilfoy, Meredith Yeager, Li Xu, William Wheeler, Michael Abend, Elaine Ron, Margaret A Tucker, Stephen J Chanock, Alice J Sigurdson.   

Abstract

DNA damage is an important mechanism in carcinogenesis, so genes related to maintaining genomic integrity may influence papillary thyroid cancer (PTC) risk. Candidate gene studies targeting some of these genes have identified only a few polymorphisms associated with risk of PTC. Here, we expanded the scope of previous candidate studies by increasing the number and coverage of genes related to maintenance of genomic integrity. We evaluated 5077 tag single-nucleotide polymorphisms (SNPs) from 340 candidate gene regions hypothesized to be involved in DNA repair, epigenetics, tumor suppression, apoptosis, telomere function and cell cycle control and signaling pathways in a case-control study of 344 PTC cases and 452 matched controls. We estimated odds ratios for associations of single SNPs with PTC risk and combined P values for SNPs in the same gene region or pathway to obtain gene region-specific or pathway-specific P values using adaptive rank-truncated product methods. Nine SNPs had P values <0.0005, three of which were in HDAC4 and were inversely related to PTC risk. After multiple comparisons adjustment, no SNPs remained associated with PTC risk. Seven gene regions were associated with PTC risk at P < 0.01, including HUS1, ALKBH3, HDAC4, BAK1, FAF1_CDKN2C, DACT3 and FZD6. Our results suggest a possible role of genes involved in maintenance of genomic integrity in relation to risk of PTC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21642358      PMCID: PMC3166197          DOI: 10.1093/carcin/bgr100

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  65 in total

1.  Association of polymorphisms in ERCC2 gene with non-familial thyroid cancer risk.

Authors:  Susana N Silva; Octávia Monteiro Gil; Vanessa C Oliveira; Marisa N Cabral; Ana Paula Azevedo; Ana Faber; Isabel Manita; Teresa Cruz Ferreira; Edward Limbert; Julieta Esperança Pina; José Rueff; Jorge Gaspar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-10       Impact factor: 4.254

2.  Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.

Authors:  Anna Enjuanes; Yolanda Benavente; Francesc Bosch; Idoia Martín-Guerrero; Dolors Colomer; Susana Pérez-Alvarez; Oscar Reina; Maria T Ardanaz; Pedro Jares; Africa García-Orad; Miguel A Pujana; Emili Montserrat; Silvia de Sanjosé; Elias Campo
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

3.  RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.

Authors:  A K Siraj; M Al-Rasheed; M Ibrahim; K Siddiqui; F Al-Dayel; O Al-Sanea; S Uddin; K Al-Kuraya
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

4.  Association and interactions between DNA repair gene polymorphisms and adult glioma.

Authors:  Yanhong Liu; Michael E Scheurer; Randa El-Zein; Yumei Cao; Kim-Anh Do; Mark Gilbert; Kenneth D Aldape; Qingyi Wei; Carol Etzel; Melissa L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

5.  Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.

Authors:  Ana Vega; Antonio Salas; Roger L Milne; Begoña Carracedo; Gloria Ribas; Alvaro Ruibal; Antonio Cabrera de León; Ana González-Hernández; Javier Benítez; Angel Carracedo
Journal:  Gynecol Oncol       Date:  2008-10-23       Impact factor: 5.482

Review 6.  Human DNA repair genes, 2005.

Authors:  Richard D Wood; Michael Mitchell; Tomas Lindahl
Journal:  Mutat Res       Date:  2005-09-04       Impact factor: 2.433

7.  A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value.

Authors:  Brian A Walker; Paola E Leone; Laura Chiecchio; Nicholas J Dickens; Matthew W Jenner; Kevin D Boyd; David C Johnson; David Gonzalez; Gian Paolo Dagrada; Rebecca K M Protheroe; Zoe J Konn; David M Stockley; Walter M Gregory; Faith E Davies; Fiona M Ross; Gareth J Morgan
Journal:  Blood       Date:  2010-07-08       Impact factor: 22.113

8.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

9.  Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase.

Authors:  John K Wiencke; Kenneth Aldape; Alex McMillan; Joe Wiemels; Michelle Moghadassi; Rei Miike; Karl T Kelsey; Joe Patoka; Jeff Long; Margaret Wrensch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-07       Impact factor: 4.254

10.  Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysis.

Authors:  Wen-Yi Huang; Andrew F Olshan; Stephen M Schwartz; Sonja I Berndt; Chu Chen; Victor Llaca; Stephen J Chanock; Joseph F Fraumeni; Richard B Hayes
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-07       Impact factor: 4.254

View more
  19 in total

1.  Common genetic variants in the 8q24 region and risk of papillary thyroid cancer.

Authors:  Gila Neta; Chu-Ling Yu; Alina Brenner; Fangyi Gu; Amy Hutchinson; Ruth Pfeiffer; Erich M Sturgis; Li Xu; Martha S Linet; Bruce H Alexander; Stephen Chanock; Alice J Sigurdson
Journal:  Laryngoscope       Date:  2012-01-24       Impact factor: 3.325

2.  Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.

Authors:  Alice J Sigurdson; Alina V Brenner; James A Roach; Lilia Goudeva; Jörg A Müller; Kai Nerlich; Christoph Reiners; Robert Schwab; Liliane Pfeiffer; Melanie Waldenberger; Melissa Braganza; Li Xu; Erich M Sturgis; Meredith Yeager; Stephen J Chanock; Ruth M Pfeiffer; Michael Abend; Matthias Port
Journal:  Carcinogenesis       Date:  2016-04-28       Impact factor: 4.944

Review 3.  Multi-substrate selectivity based on key loops and non-homologous domains: new insight into ALKBH family.

Authors:  Baofang Xu; Dongyang Liu; Zerong Wang; Ruixia Tian; Yongchun Zuo
Journal:  Cell Mol Life Sci       Date:  2020-07-08       Impact factor: 9.261

Review 4.  Genetic predisposition for nonmedullary thyroid cancer.

Authors:  Rebecca Nagy; Matthew D Ringel
Journal:  Horm Cancer       Date:  2014-10-22       Impact factor: 3.869

5.  Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk.

Authors:  Sara J Schonfeld; Gila Neta; Erich M Sturgis; Ruth M Pfeiffer; Amy A Hutchinson; Li Xu; William Wheeler; Pascal Guénel; Preetha Rajaraman; Florent de Vathaire; Elaine Ron; Margaret A Tucker; Stephen J Chanock; Alice J Sigurdson; Alina V Brenner
Journal:  Thyroid       Date:  2012-01-06       Impact factor: 6.568

Review 6.  Genetic determinants of neuronal vulnerability to apoptosis.

Authors:  Angeles Almeida
Journal:  Cell Mol Life Sci       Date:  2012-06-14       Impact factor: 9.261

7.  Common obesity-related genetic variants and papillary thyroid cancer risk.

Authors:  Cari M Kitahara; Gila Neta; Ruth M Pfeiffer; Deukwoo Kwon; Li Xu; Neal D Freedman; Amy A Hutchinson; Stephen J Chanock; Erich M Sturgis; Alice J Sigurdson; Alina V Brenner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-11       Impact factor: 4.254

8.  Papillary thyroid cancer and inflammatory bowel disease: is there a relationship?

Authors:  Irene S Sonu; Wojciech Blonski; Ming Valerie Lin; James Lewis; Faten Aberra; Gary R Lichtenstein
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

9.  XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-analysis of case-control studies.

Authors:  Yi Bao; Lei Jiang; Jue-Yu Zhou; Jun-Jie Zou; Jiao-Yang Zheng; Xiang-Fang Chen; Zhi-Min Liu; Yong-Quan Shi
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

10.  ICAD deficiency in human colon cancer and predisposition to colon tumorigenesis: linkage to apoptosis resistance and genomic instability.

Authors:  Youssef Errami; Hassan Brim; Karine Oumouna-Benachour; Mustapha Oumouna; Amarjit S Naura; Hogyoung Kim; Jihang Ju; Christian J Davis; Jong G Kim; Hassan Ashktorab; Kenneth Fallon; Ming Xu; Jianhua Zhang; Luis Del Valle; A Hamid Boulares
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.